Primeadine
Primeadine

Investment

Investing in the age of Longevity: Investment panel

The Longevity Week: Master Investor Masterclass The Investment Panel investigates demonstrated Longevity growth, name-checking some hot areas for investment, seeing how Longevity-ready institutional investors are...

AgeX Therapeutics reports Q3 financial results

AgeX commercialises its stem cell lines with continued support from stakeholder Juvenescence. Biotech AgeX Therapeutics reported financial and operating results for the third quarter ended...

Investing in the age of Longevity: Science panel

The Longevity Week: Master Investor Masterclass It was the Longevity Forum's Longevity Week this week and this Science Panel, supported by Master Investor, benchmarks current...

LongeVC launches new $35m Longevity investment fund

A new early-stage longevity investment fund in the Baltics gets underway targeting seed and pre-A Longevity rounds. Latvian investment group LongeVC has announced its first...

Equity funding pro joins the First Longevity Board

Tom Britton steps up from Longevity firm’s Advisory Panel to full Board member. Earlier this year, SyndicateRoom co-founder Tom Britton joined First Longevity’s Advisory Panel....

Wearable firm switches focus to enterprise

Biostrap raising funds to open up consumer wearable tech for businesses to build their own biometric monitoring platforms. Since 2016, Los Angeles based wearable tech...

Helping professionals biohack personalised health

We speak to the founder of Aimee Health – currently raising seed funding for its nutrition monitoring AI platform. Californian nutrition health start-up Aimee Health is on...

Longevity Forum: Investing in the age of Longevity

We're on the verge of a lifespan revolution – it's time to jump in. The Longevity Forum is taking the lifespan to the masses next...

Healthspan wearables and subscription services are hot!

Whoopee! Health monitoring firm bags $100 million in funding: WHOOP valued at $1.2 billion in Series E financing led by IVP. Health monitoring company WHOOP...

The natural medicine war chest to fight aging

Quicksilver's liposomal delivery system boasts a non-invasion of the body patchers. Colorado-based Quicksilver Scientific manufactures a range of supplements from immunity boosters to NAD+. By...

Jim Mellon and Phil Newman: Longevity interviews

Master Investor is a publication that helps private investors to take charge of their financial destiny: covering a range of subjects, from shares to...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...

Neurotech2020: It’s a brave new world

It's an online conference, but not as you know it. Say goodbye to Zoom fatigue and hello to Neurotech2020. Understanding the brain, consciousness and thought...

Why government must unlock biotech’s potential to maximise Longevity

Breanna Deutsch joins us for a guest editorial to advocate for the increased prioritisation of government funding for Longevity in the US. Breanna Deutsch has...

Longevity big-hitters join our current investment round

Some news of our own: Key investors join the First Longevity funding round. Among those participating in this second stage funding for First Longevity are...

Juvenescence float will be well-prepared and pivotal

The aphorism "a rising tide lifts all boats" could soon apply to Longevity as Juvenescence's public debut might be less than a year away. When...

Startup Showcase: Rejuvenate Biomed: What do you think?

Rejuvenate Biomed are ready to take their first Longevity therapy into clinical trials: Invest, buy, or both? It's time to have your say on...

Jinfiniti’s Startup Showcase success drives collaboration

Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases. Augusta University spin-out Jinfiniti was our first Startup Showcase, and they...

Tina Woods: Prevention is vital for Longevity

Longevity International’s Tina Woods tells us how the Longevity industry is releasing us from being trapped in the cycle of ill health and chronic...

Proposed budget cut: reduced Longevity for EU citizens?

European Longevity Initiative writes an open letter addressing concerns that the European Research Council's budget has been cut. Suggested changes to the proposed ERC budget...
Primeadine
lumen

Latest articles

Targeting inflammaging: the hidden “inflammapath” inside us

Keystone Bio seeks funding as it gears up for clinical trials of therapeutic targeting the “keystone pathogen” of chronic inflammaging. Lurking in the mouths of...

Hyperbaric oxygen therapy: a commercial Longevity treatment?

Hyperbaric oxygen therapy can significantly decrease aging characteristics – does it have a future as a commercial Longevity treatment? Aging is made up of many...

Senescence: a new weapon in the fight against cancer

Targeting senescent “zombie” cells may improve cancer survival rates. How well women with cervical cancer respond to treatment (and survive) correlates with the level of...

Wearables and AI on the frontline of Longevity

Disruptive platforms are set for huge growth ahead of the inevitable consolidation and acquisitions: the race is on. Rise and fall used to be the...